Bio Solution Co.,Ltd. (KOSDAQ: 086820)
South Korea
· Delayed Price · Currency is KRW 14,420
-270 (-1.84%)
Oct 14, 2024, 12:48 PM KST
Bio Solution Co.,Ltd. Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2020 | FY 2019 |
|---|---|---|---|
Period Ending | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Cash & Equivalents | 3,610 | 3,393 | 1,510 |
| Short-Term Investments | - | - | 7,000 |
| Trading Asset Securities | 32,813 | 32,812 | 31,970 |
| Cash & Short-Term Investments | 36,422 | 36,204 | 40,480 |
| Cash Growth | -10.02% | -10.56% | - |
| Accounts Receivable | 2,882 | 2,726 | 3,416 |
| Other Receivables | 140.32 | 76.54 | 156.9 |
| Receivables | 3,022 | 2,803 | 3,573 |
| Inventory | 1,333 | 1,328 | 529.81 |
| Other Current Assets | 466.78 | 352.07 | 210.52 |
| Total Current Assets | 41,244 | 40,687 | 44,793 |
| Property, Plant & Equipment | 4,969 | 5,230 | 4,105 |
| Long-Term Investments | - | 0 | 0 |
| Other Intangible Assets | 772.69 | 830.46 | 847.15 |
| Long-Term Accounts Receivable | - | 0 | -0 |
| Long-Term Deferred Charges | 1,435 | 1,282 | 292.11 |
| Other Long-Term Assets | 1,792 | 1,769 | 1,770 |
| Total Assets | 50,213 | 49,798 | 51,807 |
| Accounts Payable | 414.43 | 195.36 | 98.93 |
| Accrued Expenses | 184.25 | 165.83 | 164.79 |
| Current Portion of Leases | 782.79 | 781.17 | 610.9 |
| Other Current Liabilities | 1,190 | 878.29 | 1,937 |
| Total Current Liabilities | 2,572 | 2,021 | 2,812 |
| Long-Term Leases | 458.12 | 653.01 | 150.49 |
| Other Long-Term Liabilities | 131.4 | 125.99 | 223.53 |
| Total Liabilities | 3,594 | 3,134 | 3,711 |
| Common Stock | 4,046 | 4,046 | 4,018 |
| Additional Paid-In Capital | 57,062 | 57,062 | 56,478 |
| Retained Earnings | -14,731 | -14,676 | -12,706 |
| Comprensive Income & Other | 242.74 | 233.03 | 306.39 |
| Shareholders' Equity | 46,619 | 46,664 | 48,097 |
| Total Liabilities & Equity | 50,213 | 49,798 | 51,807 |
| Total Debt | 1,241 | 1,434 | 761.4 |
| Net Cash (Debt) | 35,181 | 34,770 | 39,718 |
| Net Cash Growth | -11.42% | -12.46% | - |
| Net Cash Per Share | 4412.91 | 4366.01 | 5051.68 |
| Filing Date Shares Outstanding | 7.97 | 7.97 | 7.92 |
| Total Common Shares Outstanding | 7.97 | 7.97 | 7.92 |
| Working Capital | 38,673 | 38,667 | 41,981 |
| Book Value Per Share | 5848.18 | 5853.79 | 6076.05 |
| Tangible Book Value | 45,847 | 45,834 | 47,249 |
| Tangible Book Value Per Share | 5751.25 | 5749.62 | 5969.03 |
| Machinery | 5,782 | 5,596 | 4,595 |
| Construction In Progress | 1,229 | 1,229 | 856.1 |
Source: S&P Capital IQ. Standard template. Financial Sources.